Background: Nowadays, there is a significant but variable correlation between the diffuse large B-cell lymphoma (DLBL) and the platelet-lymphocyte ratio (PLR). This meta-analysis will assess this association. Methods: A thorough search was done up until June 2022, and 11 research revealed 2284 patients with DLBL. They discovered a connection between DLBL and the PLR. A fixed or random-effect model was used to construct odds ratios (ORs) with 95% confidence intervals (CIs) and examine the prognostic significance of the PLR on overall survival, progression-free survival, and a variety of clinicopathological characteristics. Results: Poor 5-years overall survival (OR, 0.59; 95% CI, p<0.001), poor 2-years progression-free survival subjects (OR, 0.42; 95% CI, p<0.001), and poor 5-years progression-free survival (OR, 0.50; 95% CI, p<0.001) were all significantly correlated with high the PLR. In a similar manner, a high the PLR was strongly correlated with the presence of B-symptoms (